Oric Pharmaceuticals ORIC
NASDAQ ORIC
$13.45 +0.08 (+0.60%)
As of: Sep 30, 2026 · 10:25 AM EDT

Oric Pharmaceuticals (ORIC) Capital Expenditures (2019 - 2026)

Updated

Oric Pharmaceuticals' Capital Expenditures was $356,000 in Q2 2026, up 465.1% from $63,000 a year earlier.

Analysis

Oric Pharmaceuticals (ORIC) Capital Expenditures (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oric Pharmaceuticals' Capital Expenditures was $620,000 through Jun 30, 2026, down 43.0% year-over-year; for FY2025, it was $712,000, down 40.1% from FY2024.

  • Capital Expenditures shows a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $1.19 million in FY2024 (+39.9%), $849,000 in FY2023 (-59.1%), $2.08 million in FY2022 (+121.3%) and $939,000 in FY2021 (+40.8%).
  • The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q1 2025.
  • Compared with a year earlier, Capital Expenditures was higher in five of the last eight quarters, with growth averaging 125.1%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q2 2026 (growth of 465.1%); the worst was Q1 2026 (a decline of 99.5%).
  • Per Business Quant data, ORIC's Capital Expenditures in the three quarters before Q2 2026 was $2,000 (Q1 2026), $227,000 (Q4 2025) and $35,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Oric Pharmaceuticals 1.38 Bn 1.38 Bn - 356,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 356,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 227,000.00
Sep 30, 2025 35,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 387,000.00
Dec 31, 2024 219,000.00
Sep 30, 2024 418,000.00
Jun 30, 2024 333,000.00
Mar 31, 2024 218,000.00
Dec 31, 2023 57,000.00
Sep 30, 2023 77,000.00
Jun 30, 2023 405,000.00
Mar 31, 2023 310,000.00
Dec 31, 2022 287,000.00
Sep 30, 2022 401,000.00
Jun 30, 2022 667,000.00
Mar 31, 2022 723,000.00
Dec 31, 2021 389,000.00
Sep 30, 2021 233,000.00
API Access

Oric Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ORIC&period=max&api_key=YOUR_API_KEY